Trevi Therapeutics (TRVI) Non-Current Debt (2020 - 2022)
Trevi Therapeutics (TRVI) posted quarterly Non-Current Debt of $2.2 million for Q4 2022, down 75.14% year-over-year from $8.7 million in Q4 2021, and down 43.39% quarter-over-quarter from $3.8 million in Q3 2022.
Trevi Therapeutics (TRVI) Non-Current Debt (2020 - 2022) Analysis & Trends
Trevi Therapeutics' Non-Current Debt history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2022.
- In Q4 2022, Non-Current Debt fell 75.14% year-over-year to $2.2 million; the TTM figure through Dec 2022 stood at $2.2 million (down 75.14% YoY), while the FY2022 annual figure was $2.2 million, down 75.14% from the prior year.
- Non-Current Debt for Q4 2022 stood at $2.2 million, down from $3.8 million in the prior quarter.
- The five-year high for Non-Current Debt was $14.0 million in Q4 2020, with the low at $2.2 million in Q4 2022.
- The 3-year median for Non-Current Debt is $9.4 million (2021), against an average of $9.1 million.
- The sharpest annual moves came in 2021 and 2022: Non-Current Debt slipped 25.75% in 2021, then tumbled 75.14% in 2022.
- Trevi Therapeutics' Non-Current Debt stood at $14.0 million in 2020, then slumped by 38.0% to $8.7 million in 2021, then sank by 75.14% to $2.2 million in 2022.
- Business Quant data shows TRVI's Non-Current Debt at $2.2 million in Q4 2022, $3.8 million in Q3 2022, and $5.4 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.15 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 5.43 Mn |
| Mar 31, 2022 | 7.06 Mn |
| Dec 31, 2021 | 8.65 Mn |
| Sep 30, 2021 | 10.25 Mn |
| Jun 30, 2021 | 11.91 Mn |
| Mar 31, 2021 | 13.52 Mn |
| Dec 31, 2020 | 13.95 Mn |
| Sep 30, 2020 | 13.80 Mn |